NCT03487770View on ClinicalTrials.gov

Aripiprazole Oral Solution in the Treatment of Children and Adolescents With Autistic Disorder

PHASE3CompletedINTERVENTIONAL
Enrollment

111

Participants

Timeline

Start Date

April 9, 2018

Primary Completion Date

April 21, 2020

Study Completion Date

April 21, 2020

Conditions
Autistic Disorder
Interventions
DRUG

Aripiprazole Oral Solution

Aripiprazole 2\~15 mg/day (2\~15 mL/day)

DRUG

Placebo Oral Solution

Placebo 2\~15 mg/day (2\~15 mL/day)

Trial Locations (1)

100191

6th affiliated hospital, Peking University, Beijing

Sponsors
All Listed Sponsors
lead

Otsuka Beijing Research Institute

INDUSTRY